Project Grant R01DA064508
Award Date 9/1/25
Completion Date 5/31/30
Dollars Obligated $752K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Worcester, MA 01655, USA
Similar Awards
- The National Institute on Drug Abuse (NIDA), under CFDA Program 93.279 - Drug Use and Addiction Research Programs, awarded a $1,548,605 Project Grant to the University of Massachusetts Medical School (UMMS) to test the effectiveness of the Jail ECHO Operations, Planning, and Strategy (J-ECHO OPS) implementation strategy to increase access to Medication for Opioid Use Disorder (MOUD) in rural jails. The study, titled "Improving Jail Response to the Overdose Crisis: A Hybrid Trial of Jail...
- This $147,486 federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will support a mixed-methods study examining the predictors and outcomes of methadone and buprenorphine receipt during incarceration. The study will analyze a longitudinal database on health service use and outcomes among 4,558 incarcerated individuals who received these medications from 2016-2023 at a unified jail and prison system in the Northeast....
- The National Institute on Drug Abuse (NIDA) has awarded a $731,275 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Massachusetts Medical School (UMMS) to support the "Supporting Treatment Access and Recovery in Re-entry (STAR-R)" study. The 5-year study will evaluate the effectiveness of the "Maintaining Independence and Sobriety through Systems Integration, Outreach, and Networking-Criminal Justice Version (MISSION-CJ)"...
- This Project Grant award of $722,917 from the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, will fund a 5-year study to evaluate a new approach for dispensing methadone to incarcerated individuals with opioid use disorder (OUD) in three state prison systems. The project aims to support widespread implementation of the hospital/clinic designation, which allows carceral facilities to stock and dispense methadone for OUD treatment, by launching a...
- This Cooperative Agreement award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $352,064 to The McLean Hospital Corporation in Belmont, MA to develop and validate a novel clinical outcome assessment measure of substance-related consequences for use in substance use disorder (SUD) treatment trials. The overarching aim is to create a patient-reported outcome measure that can serve as a valuable endpoint for SUD...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $823,809 to the University of Pittsburgh to develop and validate a suite of multidimensional measures of access to Medications for Opioid Use Disorder (MOUD) across U.S. states and the District of Columbia. The primary objectives are to: Create a Small Area Multidimensional MOUD Access (SAMMA) measure suite using public data sources. Validate and...
- This federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a clinical research hub to study the implementation and impact of a Medicaid Inmate Exclusion Policy (MIEP) waiver in 4 Massachusetts county jails. The $1,600,955 award, effective from Sep 1, 2025 to May 31, 2030, will be administered by the University of Massachusetts. The research aims to understand how the MIEP waiver, which...
- This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $187,023 to Baystate Medical Center, Inc. in Massachusetts. The purpose is to conduct a mixed-methods study to determine the impact of the state's Behavioral Health Supports for Justice-Involved Individuals (BH-JI) program on healthcare utilization, costs, and overdose outcomes for individuals with opioid use disorder (OUD) upon release from...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, will evaluate the benefits of a hand-held, automated, personalized oral liquid dispensing system for take-home methadone medication management for patients with opioid use disorder (OUD). The $326,410 award, with a performance period from June 1, 2025 to May 31, 2026, will support a clinical program delivered by Berkshire Biomedical Corporation. The project aims to...
- The U.S. Centers for Disease Control and Prevention (CDC), through the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136), awarded a $449,998 Cooperative Agreement to the University of Pennsylvania to support the "PRAGMATIC IMPLEMENTATION OF STRATEGIC INTERVENTIONS TO IMPROVE INITIATION OF MOUD WITHIN EMERGENCY DEPARTMENTS." The project aims to develop and implement effective practices for preventing injuries and violence, with a focus on...